Get startedLog in
    Picture of Integrated Diagnostics Holdings logo

    IDHC — Integrated Diagnostics Holdings Income Statement

    0.000.00%
    gb flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapSuper Stock
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Integrated Diagnostics Holdings, fiscal year end - December 31st, EGP millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue2,6565,2253,6054,1235,720
    Cost of Revenue
    Gross Profit1,3432,8041,4621,5242,182
    Selling / General / Administrative Expenses
    Depreciation and Amortization
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses1,6712,9632,7733,3854,505
    Operating Profit9862,2628327381,214
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes9692,2328547371,440
    Provision for Income Taxes
    Net Income After Taxes6091,4935274681,008
    Minority Interest
    Net Income Before Extraordinary Items
    Net Income5941,4135415101,077
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income5941,4135415101,077
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS0.992.350.9250.9011.85
    Dividends per Share